⌘K

Login Start Free

NPS PHARMACEUTICALS INC·4/A

Sep 15, 6:56 PM ET

CLARK DAVID L 4/A

4/A · NPS PHARMACEUTICALS INC · Filed Sep 15, 2003

Insider Transaction Report

Form 4/AAmended

Period: 2003-09-10

NPS PHARMACEUTICALS INCNPSP

VP, Corporate Affairs

Transactions

Exercise/Conversion
Common Stock
2003-09-10$4.50/sh+800$3,600→ 4,131 total
Exercise/Conversion
Stock Option
2003-09-10$4.50/sh−800$3,600→ 1,200 total
Exercise: $4.50From: 2000-12-08Exp: 2009-12-08→ Common Stock (800 underlying)
Exercise/Conversion
Stock Option
2003-09-10$6.63/sh−3,600$23,850→ 4,500 total
Exercise: $6.63From: 1999-12-04Exp: 2008-12-04→ Common Stock (3,600 underlying)
Sale
Common Stock
2003-09-10$30.91/sh−11,600$358,605→ 3,331 total
Exercise/Conversion
Stock Option
2003-09-10$10.75/sh−7,200$77,400→ 4,400 total
Exercise: $10.75From: 2001-05-24Exp: 2010-05-24→ Common Stock (7,200 underlying)
Exercise/Conversion
Common Stock
2003-09-10$6.63/sh+3,600$23,850→ 7,731 total
Exercise/Conversion
Common Stock
2003-09-10$10.75/sh+7,200$77,400→ 14,931 total

Footnotes (1)

[F1]This transaction was executed under a Rule 10b5-1 trading plan.

Documents

1 file

4
edgar.xml
PRIMARY DOCUMENT